The Russian Society of Obstetricians and Gynecologists (RSOG) led by Acad.
The entry works should be related to Longidaze® (bovhualuronidase azoximer) application in pelvic inflammatory diseases, endometriosis,
The contest duration is early April — September. The physicians filing the best cases will win the recognition among the colleagues and awards.
The award ceremony will be held within the framework of the annual
For more details, please go to the RSOG website: www.roagkonkurs.ru
Longidaze is an advanced sustained release enzyme for combined therapy of connective tissue hyperplasia diseases (adhesion, scarring, or fibrous processes). This product has been successfully used in gynecology for 10 years, and due to its broad therapeutic indication spectrum, physicians have gained vast experience of its clinical use that they can share with the scientific community at large and their colleagues.